Richard B. Slansky, Chief Financial Officer at GenMark Diagnostics, Inc. (GNMK), sold 2,302 shares at $9.26 ($21K) on 2014-05-08, disclosed to the SEC on 2014-05-12.
Scheduled sale ($21k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| GNMK | SELL | 2014-03-13 | $20K | — | Filing → |
| GNMK | SELL | 2014-02-07 | $10K | — | Filing → |
| GNMK | SELL | 2013-11-08 | $8K | — | Filing → |